CY2363B1 - Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria. - Google Patents

Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria.

Info

Publication number
CY2363B1
CY2363B1 CY0300045A CY0300045A CY2363B1 CY 2363 B1 CY2363 B1 CY 2363B1 CY 0300045 A CY0300045 A CY 0300045A CY 0300045 A CY0300045 A CY 0300045A CY 2363 B1 CY2363 B1 CY 2363B1
Authority
CY
Cyprus
Prior art keywords
pyridylmethylsulphinyl
treatment
helicobacter bacteria
illnesses caused
derivates
Prior art date
Application number
CY0300045A
Inventor
Kurt Klemm
Uwe Krueger
Ernst Sturm
Joerg Senn-Bilfinger
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25689847&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2363(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of CY2363B1 publication Critical patent/CY2363B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention concerns the use of compound of formula (I), in which the substituents and symbols are as defined in the specification, against Helicobacter bacteria.
CY0300045A 1990-09-14 2003-05-30 Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria. CY2363B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH299390 1990-09-14
CH222691 1991-07-25

Publications (1)

Publication Number Publication Date
CY2363B1 true CY2363B1 (en) 2004-06-04

Family

ID=25689847

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300045A CY2363B1 (en) 1990-09-14 2003-05-30 Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria.

Country Status (13)

Country Link
EP (1) EP0548103B1 (en)
JP (1) JPH06500547A (en)
AT (1) ATE209914T1 (en)
AU (1) AU8445791A (en)
CA (1) CA2092694C (en)
CY (1) CY2363B1 (en)
DE (1) DE59109225D1 (en)
DK (1) DK0548103T3 (en)
ES (1) ES2169022T3 (en)
IE (1) IE913232A1 (en)
IL (1) IL99471A (en)
NZ (1) NZ239772A (en)
WO (1) WO1992004898A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105155A (en) * 1992-04-24 1999-05-09 Astra Ab Combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
AU674058B2 (en) * 1993-02-17 1996-12-05 Altana Pharma Ag Substituted heteroarylalkylthiopyridines for controlling helicobacter bacteria
WO1994027606A1 (en) * 1993-05-28 1994-12-08 Unisearch Limited Method of treating helicobacter pylori infection
JPH0717971A (en) * 1993-07-02 1995-01-20 Takeda Chem Ind Ltd Imidazole derivative, production and use thereof
EP0711282B1 (en) * 1993-07-28 2002-06-05 Aventis Pharma Limited Compounds as pde iv and tnf inhibitors
EP0642797B1 (en) * 1993-09-09 2000-05-17 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
WO1997040039A1 (en) * 1996-04-23 1997-10-30 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compounds and medicinal uses thereof
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
JPH03504497A (en) * 1988-05-25 1991-10-03 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング New fluoroalkoxy compound
JP2694361B2 (en) * 1989-02-09 1997-12-24 アストラ アクチエボラグ Antibacterial agent
DK0382489T3 (en) * 1989-02-10 1995-01-16 Takeda Chemical Industries Ltd Monoclonal Anti-Human Papillomavirus Antibody, Hybridoma Cell Producing This, and Method of Preparation thereof

Also Published As

Publication number Publication date
ES2169022T3 (en) 2002-07-01
IE913232A1 (en) 1992-02-25
IL99471A0 (en) 1992-08-18
DK0548103T3 (en) 2002-04-02
ATE209914T1 (en) 2001-12-15
JPH06500547A (en) 1994-01-20
DE59109225D1 (en) 2002-01-17
IL99471A (en) 1996-03-31
EP0548103A1 (en) 1993-06-30
WO1992004898A1 (en) 1992-04-02
CA2092694C (en) 2005-04-05
EP0548103B1 (en) 2001-12-05
NZ239772A (en) 1997-03-24
CA2092694A1 (en) 1992-03-15
AU8445791A (en) 1992-04-15

Similar Documents

Publication Publication Date Title
TW218869B (en)
DK1200418T3 (en) Nematodicidal trifluorobutene
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
ZA919629B (en) Novel 4-arylpiperazines and 4-arylpiperidines
BG105270A (en) Tetrahydropyridoethers
CY2538B1 (en) Tetrahydropyrido compounds
NZ507350A (en) Semi-synthetic ecteinascidins and use in treatment of tumors
MX9606300A (en) Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria.
CY2363B1 (en) Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria.
SI1086096T1 (en) Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
MXPA02009549A (en) Tricyclic imidazopyridines.
EA199900534A1 (en) IMIDAZOPIRIDAZINS
MX9700624A (en) Imidazopyridine-azolidinones.
BG98238A (en) Substituted benzothiazole derivatives, methods for their preparation and their application as herbicides
MX9606295A (en) Thiopyridines for use in the control of helicobacter bacteria.
ES470430A1 (en) Synthetic aminoglycosides
MX9700524A (en) Thiopyridyl compounds for controlling helicobacter bacteria.
UA16247A1 (en) N-(3-chloro-1,4-naphthoquinonyl-2)-2-d,l-asparagic acid having cardiokinetic properties
UA33933A (en) Lymphagogue
UA19097A (en) D-1-phenyl-2 methylaminopropanol-1-5,6,7-trioxyflavon-7-0-BETA-D-glukuronidate having antioxidative and vasodilating activity
SU1561277A1 (en) DISINFECTANT